HLX17
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HLX17, covering 2025-02-26 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors [Phase 1]